UK markets open in 1 hour 58 minutes

Apontis Pharma AG (APPH.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
8.00-0.16 (-1.96%)
At close: 09:49PM CET
Full screen
Previous close8.16
Open8.46
Bid0.00 x N/A
Ask0.00 x N/A
Day's range8.00 - 8.46
52-week range5.90 - 18.00
Volume242
Avg. volume371
Market cap72.59M
Beta (5Y monthly)N/A
PE ratio (TTM)18.18
EPS (TTM)0.44
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est27.70
  • EQS Group

    APONTIS PHARMA: Number of announced market launches increases to ten Single Pills – Portfolio grows by two in-licensing deals

    EQS-News: APONTIS PHARMA AG / Key word(s): Product LaunchAPONTIS PHARMA: Number of announced market launches increases to ten Single Pills – Portfolio grows by two in-licensing deals 29.11.2022 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.APONTIS PHARMA: Number of announced market launches increases to ten Single Pills – Portfolio grows by two in-licensing deals Continuous expansion of the Single Pill portfolio to meet the target of at least 20 Single Pil

  • EQS Group

    APONTIS PHARMA confirms 2022 forecast after successful nine-month period – Strong Single Pill pipeline to achieve medium-term targets

    EQS-News: APONTIS PHARMA AG / Key word(s): 9 Month figures/Quarterly / Interim StatementAPONTIS PHARMA confirms 2022 forecast after successful nine-month period – Strong Single Pill pipeline to achieve medium-term targets 10.11.2022 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.APONTIS PHARMA confirms 2022 forecast after successful nine-month period – Strong Single Pill pipeline to achieve medium-term targets Superiority of Single Pill therapy confirmed in

  • EQS Group

    APONTIS PHARMA announces cooperation to launch new Single Pill in Germany

    EQS-News: APONTIS PHARMA AG / Key word(s): Alliance/Product LaunchAPONTIS PHARMA announces cooperation to launch new Single Pill in Germany 20.09.2022 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.APONTIS PHARMA announces cooperation to launch new Single Pill in Germany Single Pill for more efficient treatment of hypertension with potential peak sales of more than EUR 15.0 million Potential patient population of more than a million people Market launch pla